Blood interactions with noble metals: coagulation and immune complement activation.
Noble metals are interesting biomaterials for a number of reasons, e.g., their chemical inertness and relative mechanical softness, silver's long known antimicrobial properties, and the low allergenic response shown by gold. Although important for the final outcome of biomaterials, little is reported about early events between pure noble metals and blood. In this article, we used whole blood in the "slide chamber model" to study the activation of the immune complement activation, generation of thrombin/antithrombin (TAT) complexes, and platelet depletion from blood upon contact with silver (Ag), palladium (Pd), gold (Au), titanium (Ti), and Bactiguard, a commercial nanostructured biomaterial coating comprised of Ag, Pd, and Au. The results show the highest TAT generation and platelet depletion on Ti and Au and lower on Pd, Ag, and the Bactiguard coating. The immune complement factor 3 fragment (C3a) was generated by the surfaces in the following order: Ag > Au > Pd > Bactiguard > Ti. Quartz crystal microbalance adsorption studies with human fibrinogen displayed the highest deposition to Ag and the lowest onto the Bactiguard coating. The adsorbed amounts of fibrinogen did not correlate with thrombogenicity in terms of TAT formation and platelet surface accumulation in blood. The combined results suggest, hence, that noble metal chemistry has a different impact on the protein adsorption properties and general blood compatibility. The low thrombogenic response by the Bactiguard coating cannot be explained by any of the single noble metal properties but is likely a successful combination of the nanostructure, nanogalvanic effects, or combinatory chemical and physical materials properties.
Hulander
Mats
M
Department of Cell and Molecular Biology/Interface Biophysics, Gothenburg University, Medicinaregatan 9E, 41390 Gothenburg, Sweden. mats.hulander@cmb.gu.se
Hong
Jaan
J
Andersson
Marcus
M
Gervén
Frida
F
Ohrlander
Mattias
M
Tengvall
Pentti
P
Elwing
Hans
H
D001672:Biocompatible Materials / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects* / Q000235:genetics*; D003167:Complement Activation / Q000187:drug effects* / Q000276:immunology*; D016207:Cytokines / Q000276:immunology*; D006801:Humans; D008422:Materials Testing; D008670:Metals / Q000494:pharmacology*
D001672:Biocompatible Materials; D016207:Cytokines; D008670:Metals